The neuronal transporter gene SLC6A15 confers risk to major depression
about
The genetics of major depressionBiomarkers predicting antidepressant treatment response: how can we advance the field?Genetic determinants of depression: recent findings and future directionsInvolvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypesGenome-wide linkage on chromosome 10q26 for a dimensional scale of major depressionThe Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety DisordersMK4MDD: a multi-level knowledge base and analysis platform for major depressive disorderGenome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorderA genome-wide association study of depressive symptomsA genome-wide association study of behavioral disinhibitionA mega-analysis of genome-wide association studies for major depressive disorderGenome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium.Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant responseFRAS1-related extracellular matrix 3 (FREM3) single-nucleotide polymorphism effects on gene expression, amygdala reactivity and perceptual processing speed: An accelerated aging pathway of depression riskHypermethylation in the ZBTB20 gene is associated with major depressive disorder.Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF.Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.Premorbid risk factors for major depressive disorder: are they associated with early onset and recurrent course?SLC6 transporters: structure, function, regulation, disease association and therapeuticsCharacterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system.Functional coding variants in SLC6A15, a possible risk gene for major depression.Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Psychopathological profiles in transsexuals and the challenge of their special status among the sexesPolymorphisms of IKBKE gene are associated with major depressive disorder and panic disorderCopy number variants encompassing Mendelian disease genes in a large multigenerational family segregating bipolar disorderGenome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response.Familiality and SNP heritability of age at onset and episodicity in major depressive disorderAntidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto ratsEffects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder.Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression.Meta-analysis identifies seven susceptibility loci involved in the atopic marchThe solute carrier 6 family of transportersMulti-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder.Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.Novel multiple sclerosis susceptibility loci implicated in epigenetic regulationRecurrent major depression and right hippocampal volume: A bivariate linkage and association study.Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility.Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy.
P2860
Q26830784-A4BE2BB4-B6FD-4A96-9C23-AFA0BA0CBE44Q27026147-C6F2AD6E-54D2-48ED-AD5F-012F598464C5Q27027836-93381906-0E32-4BD0-83E0-D9071ED7D35CQ27311525-C1099CED-FC1E-431E-931B-72C513E69159Q28384381-F54CA985-E58E-4371-AB99-2326E379C316Q28396166-4142AC45-5EFF-4B10-A919-551F919B0459Q28727310-34B1C7DA-4FE0-45A3-AF4F-35A9B7A1BD40Q28943374-096E58AF-41C5-4783-8571-48280C2956E2Q28943434-11156F11-ADD6-4928-A25D-E2550C75D2CDQ28943437-DC003E9F-EBF7-4D70-8FBE-6783681A479DQ29417093-36DC9D06-F0B4-4009-90A6-E41F1299E9D6Q30300864-6C67B559-340B-4842-89AE-F08F7832256AQ30534765-25F968E6-C55A-4A23-9453-8DBEC4048FEAQ30665671-06D946FC-4DC4-4AAD-AA71-EE1E0D97A948Q33813393-1D9CA84D-9288-4724-A201-0BBDC6FAB169Q33875986-D10F6AA3-7567-4165-B908-2C01F960C2EDQ34459775-7D9B98C0-8565-490B-BD88-F13CCAAC405DQ34477135-0EA99DDB-C822-44FF-9B11-575659BDE774Q34574186-BB24CB4F-5E0E-473E-B289-2A15192BCD18Q34649517-EEB35058-6510-4616-83C2-2056A6A62968Q34721980-73916B87-4D16-467C-B6FC-F7E97B582F92Q34850013-8E04F864-D1A9-40E0-A83A-020C59A87091Q35032056-422CDEFC-FDDF-4953-8CC6-DAA276588019Q35032597-595650A9-9790-4734-9F2C-5C4410774F2BQ35169186-A219C117-E8E8-45BC-8FBE-B188C31577CEQ35246537-862B564B-9014-4A4F-B910-4A4C962C61DEQ35565624-2AE59125-9CEE-4BD8-96A1-7FFF1A08A08BQ35598795-7E2521EA-7FE6-4C8F-9779-E7B5077993F9Q35711708-7B176F3F-1B72-419B-AFC8-055250676302Q36007530-B8298EE0-98E6-4995-A0CF-743693DBE352Q36159230-00C9CFB8-647B-495B-84F4-381D4FB1A9CEQ36213137-D7AAED81-1C30-4B79-AF62-6A40BA151B38Q36341386-2A6E9A7D-70D9-4B7F-8BB9-B10545BD2D59Q36346899-AC010ABA-039B-43A6-9D7F-39CD75C93452Q36591241-BF3E4663-DA93-48B1-9F39-31B4C9BDA7C7Q36593835-9822050C-E164-4942-8BD9-65028F3F9304Q37056269-4BCD6DDA-A013-41DB-A035-83455FD69120Q37167833-F1EB81B6-8363-4C86-AAD5-17F7FD44946DQ37607938-CE085FFE-3F08-4FDA-9872-A220E9DEA42FQ37679549-73DDB6AE-3D18-4CA5-A1C5-53A4E54C7CDB
P2860
The neuronal transporter gene SLC6A15 confers risk to major depression
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The neuronal transporter gene SLC6A15 confers risk to major depression
@ast
The neuronal transporter gene SLC6A15 confers risk to major depression
@en
The neuronal transporter gene SLC6A15 confers risk to major depression
@nl
type
label
The neuronal transporter gene SLC6A15 confers risk to major depression
@ast
The neuronal transporter gene SLC6A15 confers risk to major depression
@en
The neuronal transporter gene SLC6A15 confers risk to major depression
@nl
prefLabel
The neuronal transporter gene SLC6A15 confers risk to major depression
@ast
The neuronal transporter gene SLC6A15 confers risk to major depression
@en
The neuronal transporter gene SLC6A15 confers risk to major depression
@nl
P2093
P2860
P50
P3181
P1433
P1476
The neuronal transporter gene SLC6A15 confers risk to major depression
@en
P2093
Albert Becker
Bekh Bradley
Christiane Wolf
David Hoehn
Elisabeth B Binder
Ian W Craig
Johannes Schramm
Marianne B Müller
Martin A Kohli
P2860
P304
P3181
P356
10.1016/J.NEURON.2011.04.005
P407
P50
P577
2011-04-28T00:00:00Z